Rong Zhou - 16 Sep 2026 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Sep 2026, 18:19:48 UTC
Prior SEC filing
03 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eva Wen, by power of attorney

Key filing fact

Rong Zhou filed Form 4 for Amphastar Pharmaceuticals, Inc. (AMPH) on 17 Sep 2026.

Key facts

  • This page summarizes Rong Zhou's Form 4 filing for Amphastar Pharmaceuticals, Inc. (AMPH).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Sep 2026, 18:19.

Change

  • Previous filing in this sequence was filed on 03 Sep 2026.
  • Current net transaction value: -$239,404.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001645326 Primary reporting owner

Zhou Rong

Relationship
SENIOR EVP, PRODUCTION CENTER
Address
C/O AMPHASTAR PHARMACEUTICALS, INC., 11570 6TH STREET, RANCHO CUCAMONGA
Signature
/s/ Eva Wen, by power of attorney
Signature date
17 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMPH transaction

Common Stock

Options Exercise

Transaction value
Shares
+10,000
Change %
+5.9%
Price
$13.35*
Shares after
179,203
Date
16 Sep 2026
Ownership
Direct
AMPH transaction

Common Stock

Sale

Transaction value
$239,404
Shares
-10,000
Change %
-5.6%
Price
$23.94
Shares after
169,203
Date
16 Sep 2026
Ownership
Direct
Footnotes
F1
AMPH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
99,668
Date
16 Sep 2026
Ownership
See footnote
Footnotes
F2
AMPH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,000
Date
16 Sep 2026
Ownership
See footnote
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMPH transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-10,000
Change %
-34%
Price
$0.000000*
Shares after
19,424
Date
16 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$13.35
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.83 to $24.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Footnote F2

The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.

Footnote F3

The shares are held of record by the reporting person's spouse.

Footnote F4

Shares subject to the option are fully vested and immediately exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .